KPMG is guiding the healthcare and life sciences industry in the transition from “volume to value” through advanced business transformation methodologies, coupled with our long-standing tax, audit and advisory services.

KPMG's professionals combine technical, market and business skills that enable them to deliver objective advice and guidance that help our clients grow their businesses, improve performance and manage risk more effectively.

Through customer led stories, superior executive networking, and luminary insights, this premier event addresses best practices and game-changing disrupters to help companies deliver in today’s evolving workplace.

KPMG Global CEO Study

The Fourth Industrial Revolution is here, and it’s upending business models, blurring lines between industries and companies, and demanding an entirely new way of thinking about business.

KPMG’s survey of 400 U.S. chief executives sheds light on how companies are transforming in times of extraordinary change. CEOs say that rapidly evolving technology, and the speed of transformation it unleashes, are making the next three years more critical for their industry than the previous 50. While they’re confident about their growth prospects, they recognize that they are operating in a new world – and they’ll have to operate differently to succeed.

To manage disruption and seize opportunity over the next three years, CEOs will:

intensify customer focus

develop new products

invest in disruptive technologies

engage in external partnerships

transform into significantly different entities

“The corporate playbook is being rewritten and replaced by one that takes business agility to a level we have never seen before,” says Lynne Doughtie, Chairman and CEO, KPMG LLP.

Read KPMG’s U.S. CEO Outlook 2016 for insights into the viewpoints of CEOs across a range of issues and a picture of the future direction of their companies.